BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19520457)

  • 1. [Epidemiology and prognostic factors for sickle cell retinopathy in Ouagadougou (Burkina Faso)].
    Diallo JW; Sanfo O; Blot I; Meda N; Sawadogo P; Ouedraogo A; Simporé J
    J Fr Ophtalmol; 2009 Sep; 32(7):496-500. PubMed ID: 19520457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sickle-cell retinopathy: Retrospective study of 730 patients followed in a referral center].
    Leveziel N; Lalloum F; Bastuji-Garin S; Binaghi M; Bachir D; Galacteros F; Souied E
    J Fr Ophtalmol; 2012 May; 35(5):343-7. PubMed ID: 22472104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sickle cell disease and retinal damage: a study of 38 cases at the African Tropical Ophthalmology Institute (IOTA) in Bamako].
    Traoré J; Boitre JP; Bogoreh IA; Traoré L; Diallo A
    Med Trop (Mars); 2006 Jun; 66(3):252-4. PubMed ID: 16924816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When should children and young adults with sickle cell disease be referred for eye assessment?
    Babalola OE; Wambebe CO
    Afr J Med Med Sci; 2001 Dec; 30(4):261-3. PubMed ID: 14510100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal involvement in drepanocytosis in Togo. Correlation between age, genotype and retinopathy].
    Balo KP; Fany A; Mihluedo H; Djagnikpo PA; Koffi-Gue KB
    J Fr Ophtalmol; 1997; 20(9):653-8. PubMed ID: 9587575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study.
    Downes SM; Hambleton IR; Chuang EL; Lois N; Serjeant GR; Bird AC
    Ophthalmology; 2005 Nov; 112(11):1869-75. PubMed ID: 16171867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative sickle cell retinopathy under age 20: a review.
    Kimmel AS; Magargal LE; Maizel R; Robb-Doyle E
    Ophthalmic Surg; 1987 Feb; 18(2):126-8. PubMed ID: 2437512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pediatric management of sickle cell disease: experience at the Charles de Gaulle University Children's Hospital in Ouagadougou (Burkina Faso)].
    Yé D; Kouéta F; Dao L; Kaboret S; Sawadogo A
    Sante; 2008; 18(2):71-5. PubMed ID: 19188129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell retinopathy and other chronic complications of sickle cell anemia: A clinical study of 84 Sub-Saharan African cases (Cameroon).
    Bilong Y; Dubert M; Koki G; Noubiap JJ; Pangetna HN; Menet A; Chelo D; Offredo L; Jacob S; Belinga S; Yanda ANA; Kingue S; Jouven X; Ranque B; Bella LA
    J Fr Ophtalmol; 2018 Jan; 41(1):50-56. PubMed ID: 29295792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vision-threatening eye manifestations in patients with sickle cell disease on Curaçao].
    van Meurs JC
    Ned Tijdschr Geneeskd; 1990 Sep; 134(37):1800-2. PubMed ID: 1699139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of visual loss in untreated sickle cell retinopathy.
    Moriarty BJ; Acheson RW; Condon PI; Serjeant GR
    Eye (Lond); 1988; 2 ( Pt 3)():330-5. PubMed ID: 3402630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatologic diseases and haemoglobinopathies in Ouagadougou (Burkina Faso)].
    Ouédraogo DD; Nacoulma EW; Kafando E; Ouédraogo A; Tiéno H; Koulidiaty J; Drabo JY
    Bull Soc Pathol Exot; 2010 May; 103(2):80-3. PubMed ID: 20387032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative retinopathy in sickle cell trait. Report of seven cases.
    Nagpal KC; Asdourian GK; Patrianakos D; Goldberg MF; Rabb MF; Goldbaum M; Raichand M
    Arch Intern Med; 1977 Mar; 137(3):325-8. PubMed ID: 843150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual cases of proliferative sickle retinopathy.
    Kimmel AS; Magargal LE; Barna N; Tasman W
    Trans Pa Acad Ophthalmol Otolaryngol; 1986; 38(1):332-5. PubMed ID: 3765017
    [No Abstract]   [Full Text] [Related]  

  • 15. Ocular findings in sickle cell disease patients in Lagos.
    Akinsola FB; Kehinde MO
    Niger Postgrad Med J; 2004 Sep; 11(3):203-6. PubMed ID: 15505651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence and risk factors for sickle retinopathy in a sub-Saharan comprehensive Sickle Cell Center].
    Dembélé AK; Toure BA; Sarro YS; Guindo A; Fané B; Offredo L; Kené S; Conaré I; Tessougué O; Traoré Y; Badiaga Y; Sidibé MB; Diabaté D; Coulibaly M; Kanta M; Ranque B; Diallo DA
    Rev Med Interne; 2017 Sep; 38(9):572-577. PubMed ID: 28237127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of sickle cell retinopathy.
    Siegel D
    J Am Optom Assoc; 1988 Nov; 59(11):885-8. PubMed ID: 3230242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemoglobin sickle cell disease: experience of the Yalgado Ouedraogo University Hospital of Ouagadougou, Burkina Faso].
    Ayéroué J; Kafando E; Kam L; Gué E; Vertongen F; Ferster A; Cotton F; Gulbis B
    Arch Pediatr; 2009 Apr; 16(4):316-21. PubMed ID: 19261452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination status of children with sickle cell disease in Ouagadougou (Burkina Faso)].
    Nacoulma EW; Kam L; Gue EE; Kafando E; Ayereroue J; Blot I
    Sante; 2006; 16(3):155-60. PubMed ID: 17284390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative sickle cell retinopathy: the disease and a review of its management.
    Stephens RF
    Ophthalmic Surg; 1987 Mar; 18(3):222-31. PubMed ID: 3295633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.